Immuron IMRN
NASDAQ IMRN
$1.09 -0.04 (-3.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immuron (IMRN) Return on Equity [ROE] (2021 - 2026)

Updated

Immuron (IMRN) recorded Return on Equity [ROE] of -41.12% in FY2026 (year ended Aug 28, 2026), down 39.15 percentage points from -1.98% in FY2025.

Analysis

Immuron (IMRN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

Starting with FY2016, Immuron's Return on Equity [ROE] history includes 11 fiscal years.

  • Annual Return on Equity [ROE] has a five-year change of -29.69 percentage points (FY2021 to FY2026).
  • Annual Return on Equity [ROE] has ranged from -65.49% in FY2024 to -1.98% in FY2025 over the past five years.
  • Per Business Quant data, IMRN's Return on Equity [ROE] was -1.98% in FY2025, -65.49% in FY2024 (-51.94 pp), -13.55% in FY2023 (-3.12 pp) and -10.44% in FY2022 (+1.00 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Immuron 8.80 Mn -8.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.04%
Jun 30, 2025 -50.71%
Dec 31, 2024 -60.55%
Sep 9, 2024 -175.76%
Jun 30, 2024 -130.95%
Dec 31, 2023 -87.34%
Dec 31, 2022 -75.98%
Jun 30, 2021 -123.28%
API Access

Immuron Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMRN&period=max&api_key=YOUR_API_KEY